B-cell Acute Lymphoblastic Leukemia
1 competing product in clinical development for B-cell Acute Lymphoblastic Leukemia.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mitoxantrone hydrochloride liposome Injection-based bridging therapy+ Fludarabine-based chemotherapy +CD19 CAR-T Cells | CSPC Pharmaceutical Group Limited | Phase 2 | Active | 51 |